We are live on
!
Find out more
KCM
Kingdon Capital Management Portfolio holdings
AUM
$911M
1-Year Est. Return
51.11%
This Fund
S&P 500
This Quarter
Est. Return
-2.29%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$959M
AUM Growth
+$89.9M
(+10%)
Cap. Flow
+$164M
Cap. Flow
% of AUM
17.13%
Top 10 Holdings %
Top 10 Hldgs %
50.75%
Holding
107
New
30
Increased
18
Reduced
14
Closed
25
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$33.3M |
| 2 |
Alcoa
AA
|
+$26.7M |
| 3 |
Crown Holdings
CCK
|
+$18.4M |
| 4 |
AZEK
The AZEK Co
AZEK
|
+$16.3M |
| 5 |
Intuitive Surgical
ISRG
|
+$15.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RenaissanceRe
RNR
|
+$29.6M |
| 2 |
Humana
HUM
|
+$26.5M |
| 3 |
Avery Dennison
AVY
|
+$21.2M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$20.5M |
| 5 |
Arch Capital
ACGL
|
+$17.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.26% |
| 2 | Industrials | 8.56% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Materials | 6.46% |
| 5 | Financials | 6.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Foghorn Therapeutics
FHTX
$360M
| $826K | 0.09% |
54,241
-100
| -0.2% | -$1.37K |
|
77
CALL
Beyond Air
XAIR
$3.86M
| $668K | 0.07% |
250
-375
| -60% | -$1.1M |
|
|
TMQ
78
Trilogy Metals
TMQ
$656M
| $590K | 0.06% |
561,900
-1,111,561
| -66% | -$1.47M |
|
|
NEXI
79
DELISTED
NexImmune, Inc. Common Stock
NEXI
| $497K | 0.05% |
4,718
| – | – |
|
80
InflaRx
IFRX
$271M
| $135K | 0.01% |
73,860
-251,140
| -77% | -$782K |
|
|
MSACW
81
DELISTED
Medicus Sciences Acquisition Corp. Warrant
MSACW
| $12K | ﹤0.01% |
33,332
| – | – |
|
|
EUCRW
82
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
| $11K | ﹤0.01% |
66,665
| – | – |
|
83
AbbVie
ABBV
$435B
| – | – |
-99,200
| Closed | -$13.4M |
|
|
84
Arch Capital
ACGL
$33.6B
| – | – |
-400,000
| Closed | -$17.8M |
|
85
ANI Pharmaceuticals
ANIP
$1.78B
| – | – |
-65,000
| Closed | -$3M |
|
86
argenx
ARGX
$54.1B
| – | – |
-27,889
| Closed | -$9.77M |
|
|
87
Avery Dennison
AVY
$13.4B
| – | – |
-97,847
| Closed | -$21.2M |
|
88
CALL
BridgeBio Pharma
BBIO
$16.5B
| – | – |
-100,000
| Closed | -$1.67M |
|
89
CALL
Biogen
BIIB
$30.7B
| – | – |
-94,000
| Closed | -$22.6M |
|
90
CALL
Bakkt Inc
BKKT
$337M
| – | – |
-1,200
| Closed | -$255K |
|
|
BBBY
91
CALL
Bed Bath & Beyond
BBBY
$442M
| – | – |
-77,000
| Closed | -$4.13M |
|
92
Danaher
DHR
$144B
| – | – |
-51,334
| Closed | -$15M |
|
93
PUT
Enanta Pharmaceuticals
ENTA
$400M
| – | – |
-150,000
| Closed | -$11.2M |
|
94
Goldman Sachs
GS
$303B
| – | – |
-18,000
| Closed | -$6.89M |
|
95
CALL
Haemonetics
HAE
$4B
| – | – |
-200,000
| Closed | -$10.6M |
|
|
96
Haemonetics
HAE
$4B
| – | – |
-135,000
| Closed | -$7.16M |
|
|
97
Humana
HUM
$46.2B
| – | – |
-57,029
| Closed | -$26.5M |
|
98
Johnson Controls International
JCI
$92.2B
| – | – |
-132,600
| Closed | -$10.8M |
|
99
PUT
Moderna
MRNA
$23.6B
| – | – |
-50,000
| Closed | -$12.7M |
|
100
Microsoft
MSFT
$3.71T
| – | – |
-25,000
| Closed | -$8.41M |
|
Similar funds
GC
ICP
SAA
GIG
SI
PAMI
BDP
PTC
Kingdon Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Kingdon Capital Management held 107 positions worth $959M, up 10% from $870M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Kingdon Capital Management deployed $164M of net new capital in Q1 2022, opening 30 new positions and adding to 18 existing holdings. Its largest new stake was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 289,100 shares worth $38.9M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 32% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Biohaven Pharmaceutical Holding Company Ltd., an estimated $20.5M trimmed.
- Kingdon Capital Management's largest Q1 2022 buy was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 289,100 shares worth $38.9M.
- Kingdon Capital Management added most to Amazon in Q1 2022, an estimated $15.3M increase.
- Kingdon Capital Management's biggest Q1 2022 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $20.5M.
- Kingdon Capital Management fully exited RenaissanceRe in Q1 2022, selling an estimated $29.6M.
- Kingdon Capital Management's ten largest holdings make up 51% of its $959M portfolio in Q1 2022.
- Kingdon Capital Management opened 30 new positions and closed 25 in Q1 2022.
- Kingdon Capital Management's portfolio value rose 10% quarter-over-quarter to $959M.
Based on Kingdon Capital Management's 13F filing for Q1 2022, filed 16 May 2022.